124 related articles for article (PubMed ID: 35499789)
21. Significance of Comprehensive Analysis of Preoperative Sarcopenia Based on Muscle Mass, Muscle Strength, and Physical Function for the Prognosis of Patients with Esophageal Cancer.
Kanemura T; Takeoka T; Sugase T; Urakawa S; Masuike Y; Shinno N; Hara H; Kitakaze M; Kubo M; Mukai Y; Sueda T; Hasegawa S; Akita H; Nishimura J; Wada H; Yasui M; Omori T; Miyata H
Ann Surg Oncol; 2024 Feb; 31(2):818-826. PubMed ID: 37989955
[TBL] [Abstract][Full Text] [Related]
22. Clinical effect of enteral nutrition support during neoadjuvant chemotherapy on the preservation of skeletal muscle mass in patients with esophageal cancer.
Kita R; Miyata H; Sugimura K; Tanaka K; Makino T; Yamashita K; Yamasaki M; Motoori M; Shiraishi O; Kimura Y; Yasuda T; Yano M; Doki Y
Clin Nutr; 2021 Jun; 40(6):4380-4385. PubMed ID: 33526287
[TBL] [Abstract][Full Text] [Related]
23. Postoperative pneumonia causes the loss of skeletal muscle volume and poor prognosis in patients undergoing esophagectomy for esophageal cancer.
Fujishima S; Tsujimoto H; Nagata K; Sugasawa H; Nomura S; Ito N; Harada M; Sugihara T; Ishibashi Y; Kouzu K; Shinmoto H; Kishi Y; Ueno H
Gen Thorac Cardiovasc Surg; 2021 Jan; 69(1):84-90. PubMed ID: 32914386
[TBL] [Abstract][Full Text] [Related]
24. Prognostic Significance of Sarcopenia in Patients with Esophagogastric Junction Cancer or Upper Gastric Cancer.
Kudou K; Saeki H; Nakashima Y; Edahiro K; Korehisa S; Taniguchi D; Tsutsumi R; Nishimura S; Nakaji Y; Akiyama S; Tajiri H; Nakanishi R; Kurashige J; Sugiyama M; Oki E; Maehara Y
Ann Surg Oncol; 2017 Jul; 24(7):1804-1810. PubMed ID: 28224363
[TBL] [Abstract][Full Text] [Related]
25. Prognostic significance of preoperative skeletal muscle status in patients with gastric cancer after radical gastrectomy.
Hu CL; Jin XH; Yuan ZD; Xiong SW; Zhang L; Hou JN; Ao S; Wu JL; Shi HP; Ji JF; Lyv GQ
Asia Pac J Clin Nutr; 2019; 28(3):442-449. PubMed ID: 31464390
[TBL] [Abstract][Full Text] [Related]
26. Relationship Between Early Postoperative Change in Total Psoas Muscle Area and Long-term Prognosis in Esophagectomy for Patients with Esophageal Cancer.
Matsui K; Kawakubo H; Hirata Y; Matsuda S; Mayanagi S; Irino T; Fukuda K; Nakamura R; Wada N; Kitagawa Y
Ann Surg Oncol; 2021 Oct; 28(11):6378-6387. PubMed ID: 33786679
[TBL] [Abstract][Full Text] [Related]
27. Degradation of skeletal mass in locally advanced oesophageal cancer between initial diagnosis and recurrence.
Zouhry Y; Taibi A; Durand-Fontanier S; Darbas T; Forestier G; Monteil J; Lebrun-Ly V; Fayemendy P; Leobon S; Jesus P; Deluche E
BMC Cancer; 2021 Dec; 21(1):1313. PubMed ID: 34876055
[TBL] [Abstract][Full Text] [Related]
28. Skeletal Muscle Loss during Neoadjuvant Chemotherapy Is an Independent Risk Factor for Postoperative Infectious Complications in Patients with Advanced Esophageal Cancer.
Motoori M; Fujitani K; Sugimura K; Miyata H; Nakatsuka R; Nishizawa Y; Komatsu H; Miyazaki S; Komori T; Kashiwazaki M; Iwase K; Yano M
Oncology; 2018; 95(5):281-287. PubMed ID: 30149394
[TBL] [Abstract][Full Text] [Related]
29. Skeletal muscle gauge as a prognostic factor in patients with colorectal cancer.
Park IK; Yang SS; Chung E; Cho ES; Lee HS; Shin SJ; Im YC; Park EJ; Baik SH; Lee KY; Kang J
Cancer Med; 2021 Dec; 10(23):8451-8461. PubMed ID: 34643052
[TBL] [Abstract][Full Text] [Related]
30. Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
Panje CM; Höng L; Hayoz S; Baracos VE; Herrmann E; Garcia Schüler H; Meier UR; Henke G; Schacher S; Hawle H; Gérard MA; Ruhstaller T; Plasswilm L;
Radiat Oncol; 2019 Sep; 14(1):166. PubMed ID: 31511012
[TBL] [Abstract][Full Text] [Related]
31. Postoperative Changes in Skeletal Muscle Mass Predict Survival of Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy.
Fukushima H; Nakanishi Y; Kataoka M; Tobisu KI; Koga F
Clin Genitourin Cancer; 2017 Apr; 15(2):e229-e238. PubMed ID: 27601279
[TBL] [Abstract][Full Text] [Related]
32. Impact of preoperative skeletal muscle mass and physical performance on short-term and long-term postoperative outcomes in patients with esophageal cancer after esophagectomy.
Sugimura K; Miyata H; Kanemura T; Takeoka T; Shinnno N; Yamamoto K; Omori T; Motoori M; Ohue M; Yano M
Ann Gastroenterol Surg; 2022 Sep; 6(5):623-632. PubMed ID: 36091312
[TBL] [Abstract][Full Text] [Related]
33. Impact of skeletal muscle mass in patients with unresectable gastric cancer who received palliative first-line chemotherapy based on 5-fluorouracil.
Matsunaga T; Saito H; Miyauchi W; Shishido Y; Miyatani K; Morimoto M; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
BMC Cancer; 2021 Nov; 21(1):1219. PubMed ID: 34774016
[TBL] [Abstract][Full Text] [Related]
34. Effect of Changes in Skeletal Muscle Mass on Oncological Outcomes During First-Line Sunitinib Therapy for Metastatic Renal Cell Carcinoma.
Ishihara H; Takagi T; Kondo T; Fukuda H; Yoshida K; Iizuka J; Tanabe K
Target Oncol; 2018 Dec; 13(6):745-755. PubMed ID: 30328067
[TBL] [Abstract][Full Text] [Related]
35. Impact of Skeletal Muscle Mass Reduction on Long-term Survival After Radical Resection of Gastric Cancer.
Tanaka Y; Aoyagi K; Umetani Y; Tanaka YU; Kaku H; Minami T; Isobe T; Murakami N; Fujita F; Akagi Y
Anticancer Res; 2023 Aug; 43(8):3779-3786. PubMed ID: 37500123
[TBL] [Abstract][Full Text] [Related]
36. Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer.
Huang CY; Yang YC; Chen TC; Chen JR; Chen YJ; Wu MH; Jan YT; Chang CL; Lee J
J Cachexia Sarcopenia Muscle; 2020 Apr; 11(2):534-546. PubMed ID: 31999069
[TBL] [Abstract][Full Text] [Related]
37. Impact of skeletal muscle mass in patients with recurrent gastric cancer.
Matsunaga T; Satio H; Miyauchi W; Shishido Y; Miyatani K; Murakami Y; Hanaki T; Kihara K; Yamamoto M; Tokuyasu N; Takano S; Sakamoto T; Hasegawa T; Fujiwara Y
World J Surg Oncol; 2021 Jun; 19(1):170. PubMed ID: 34116681
[TBL] [Abstract][Full Text] [Related]
38. The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer.
Dolan RD; Almasaudi AS; Dieu LB; Horgan PG; McSorley ST; McMillan DC
J Cachexia Sarcopenia Muscle; 2019 Feb; 10(1):111-122. PubMed ID: 30460764
[TBL] [Abstract][Full Text] [Related]
39. Prognostic Significance of Skeletal Muscle Loss During Early Postoperative Period in Elderly Patients with Esophageal Cancer.
Fidler MJ; Borgia JA; Bonomi PD; Shah P
Ann Surg Oncol; 2019 Nov; 26(12):3807-3808. PubMed ID: 31471841
[No Abstract] [Full Text] [Related]
40. Assessment of Sarcopenia as a Predictor of Poor Outcomes After Esophagectomy in Elderly Patients With Esophageal Cancer.
Nakashima Y; Saeki H; Nakanishi R; Sugiyama M; Kurashige J; Oki E; Maehara Y
Ann Surg; 2018 Jun; 267(6):1100-1104. PubMed ID: 28437312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
